On Monday, Inovio Pharmaceuticals Inc (NASDAQ: INO) was 6.38% up from the session before settling in for the closing price of $2.35. A 52-week range for INO has been $1.30 – $5.80.
Annual sales at Healthcare sector company grew by 22.92% over the past five years. When this article was written, the company’s average yearly earnings per share was at 52.78%. With a float of $52.72 million, this company’s outstanding shares have now reached $53.14 million.
Inovio Pharmaceuticals Inc (INO) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Inovio Pharmaceuticals Inc stocks. The insider ownership of Inovio Pharmaceuticals Inc is 0.79%, while institutional ownership is 19.10%.
Inovio Pharmaceuticals Inc (INO) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.89 earnings per share (EPS) during the time that was better than consensus figure (set at -1.13) by 0.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 52.78% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.83% during the next five years compared to 22.92% growth over the previous five years of trading.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Trading Performance Indicators
You can see what Inovio Pharmaceuticals Inc (INO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 738.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.61, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.51 in one year’s time.
Technical Analysis of Inovio Pharmaceuticals Inc (INO)
Inovio Pharmaceuticals Inc (NASDAQ: INO) saw its 5-day average volume 1.28 million, a positive change from its year-to-date volume of 1.27 million. As of the previous 9 days, the stock’s Stochastic %D was 41.48%.
During the past 100 days, Inovio Pharmaceuticals Inc’s (INO) raw stochastic average was set at 71.48%, which indicates a significant increase from 62.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.15 in the past 14 days, which was higher than the 0.14 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.45, while its 200-day Moving Average is $2.00. Nevertheless, the first resistance level for the watch stands at $2.57 in the near term. At $2.64, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.78. If the price goes on to break the first support level at $2.36, it is likely to go to the next support level at $2.22. Assuming the price breaks the second support level, the third support level stands at $2.15.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Key Stats
There are 53,143K outstanding shares of the company, which has a market capitalization of 132.86 million. As of now, sales total 220 K while income totals -107,250 K. Its latest quarter income was 70 K while its last quarter net income were -19,690 K.
